The SARS-CoV-2 Envelope Protein Is Close Enough To SARS That FDA-Approved Drugs May Work
A protein in the viruses causing COVID-19 and SARS is almost identical, which means existing FDA-approved drugs, already tested in mice infected with SARS, could improve the outcomes for COVID-19…